New Zealand markets closed

Lonza Group AG (LZAGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
601.58+4.58 (+0.77%)
At close: 03:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close597.00
Open598.38
Bid0.00 x 0
Ask0.00 x 0
Day's range595.10 - 603.90
52-week range336.03 - 673.62
Volume250
Avg. volume1,604
Market cap44.686B
Beta (5Y monthly)0.61
PE ratio (TTM)35.60
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield4.57 (0.76%)
Ex-dividend date13 May 2024
1y target estN/A
  • Business Wire

    Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies

    BOSTON & BASEL, Switzerland, June 26, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 and VX-264 programs that are currently in clinical trials.